Hydrodynamic injection is an efficient procedure for liver gene therapy in rodents but with limited efficacy in large animals, using an 'in vivo' adapted regional hydrodynamic gene delivery system. We study the ability of this procedure to mediate gene delivery in human liver segments obtained by surgical resection. Watertight liver segments were retrogradely injected from hepatic vein with a saline solution containing a plasmid bearing the enhanced green fluorescent protein (eGFP) gene, under different conditions of flow rate (1, 10 and 20 ml s -1 ) and final perfused volume. Samples were cultured for 1 to 2 days and used for microscopy and molecular analysis of gene expression. The fluorescent and immunohistochemistry studies indicated that in segments injected at X10 ml s -1 , good and wide gene expression was present in the liver sections and the molecular analysis reinforced the histological observation in a quantitative manner (index of apparent gene delivery: 10 2 -10 4 eGFP DNA copy per 100 pg of total DNA; transcription index: 10 5 -2Â10 6 eGFP RNA copy per 100 ng of total RNA). In addition, injected gold nanoparticles (15 nm diameter) suggested that DNA delivery to hepatocytes must involve a facilitated permeation process without membrane disruption. In summary, we show that retrograde venous injection of watertight human liver segment is an anadromous procedure that results in wide liver gene delivery and good gene expression. However, additional studies will be necessary to clarify the influence of the prolonged ischemia injury to hepatocytes in our model.
INTRODUCTION
The present study has been designed to explore the capacity of regionally hydrodynamic gene delivery to human liver segments, employing an 'ex vivo' catheterization procedure. Hydrodynamic gene transfer 1, 2 with naked DNA is a safe and efficient method for gene delivery, and we had reported advances in the efficacy of naked DNA gene delivery to mice liver, resulting in long-term therapeutic plasma levels of the protein encoded by the exogenous gene. 2 As the suggested mechanism underlying the important efficacy of liver gene delivery involves transient inversion of intraorgan blood flow, we had the opportunity to improve the technique and apply it to larger animals, using catheterization proceduresas suggested by preliminary results from both other authors and our own group. [3] [4] [5] The gene expression efficiency achieved by this procedure is lower than that achieved by the original mouse procedure involving hydrodynamic tail vein injection. 2 However, the results suggest that liver gene therapy is a promising strategy in which the large liver size and/or the less compliant connective tissue framework of large animals limit the efficiency of liver gene transfer. In this respect, there is experimental evidence that promising results are achieved in less elastic cardiac tissue, 6 and that outflow obstruction during DNA hepatic vein injection significantly contributes to increase the efficiency of hydrodynamic liver gene delivery. 7 As all blood vessels are sealed in surgically derived human liver segments, we employ such watertight liver segments to evaluate the efficacy of anadromous naked DNA delivery mediated by hydrodynamic retrovenous injection.
The present study shows that catheter-mediated retrograde injection of naked DNA bearing the enhanced green fluorescent protein (eGFP) marker gene in the hepatic vein of 'ex vivo' human liver segments results in wide anadromous gene delivery and gene expression, without dramatic morphological changes in the liver tissue as evidenced by electron microscopy and the liver distribution of 15 nm gold particles. We must take into consideration that having performed our experiments in liver ischemic segments of patients undergoing resection due to hepatic cancer, additional experiments are required to confirm the results in a less prolonged ischemic situation.
RESULTS

Catheterization
The catheter was placed in hepatic vein of the liver segment, and vascular permeation of the liver segment was monitored by fluoroscopy after the injection of contrast solution. Figure 1 is representative of all the experiments and shows the fluoroscopic position of the catheter with respect to its anatomical location (Figures 1a and b) and the vascular tree after the injection of 5 and 10 ml of contrast solution (Figures 1c and d) , respectively. The place where liver samples were taken for molecular analysis can be observed in Figure 1b , corresponding to the right direction of injection, zone A samples, and lateral perfusion areas, zone B samples. We cannot know if contrast solution injection affects eGFP expression as we have injected contrast in all our experiments. For this reason, we have always tried to employ the minimum necessary quantity (volume p1% segment weight).
Histological study of eGFP expression
Three different groups were analyzed by fluorescence and/or immunohistochemical procedures. One was injected at 20 ml s -1 , 1/10 volume of segment weight, and gene expression was evaluated by fluorescence microscopy (Figures 2a-c) . The second group was injected at 10 ml s -1 , 1/5 volume of segment weight, and gene expression was evaluated by immunohistochemistry (Figures 2e-g ). The last group was injected at 1 ml s -1 , 1/5 volume of segment weight, and gene expression was evaluated by both fluorescence (Figure 2d ) and immunohistochemistry (Figure 2h ) procedures. Then, small liver samples (1Â0.5 cm) measuring o1 mm in thickness were cultured, and 1 and 2 days after gene transfer we studied eGFP gene expression in histological liver sections, employing fluorescent and immunohistochemical procedures. The results show that 1 day after injection, the fluorescence was clearly observed and widely distributed in liver cryosections from liver segments injected at a 20 ml s -1 and 1/10 of the segment weight (Figures 2a-c) , thus suggesting that efficient gene delivery was achieved by this procedure. Immunohistochemistry was also employed to detect eGFP expression. In these experiments, injection was performed at 10 ml s -1 flow rate and with 1/5 segment weight volume. Specific immunostaining 1 day after injection in paraffin sections from formalin-fixed liver samples is observed in Figures 2f and g, as compared with immunohistochemistry control performed in the absence of specific primary antibody (Figure 2e ). In contrast, in livers injected with 1 ml s -1 , volume of 1/5 segment weight, a very limited fluorescence was observed in two of the four liver segments studied. Even in those cases, only two or three microscopic fields of the whole histological section showed a very light fluorescence (Figure 2d ). Moreover, in our hands, the immunohistochemistry staining was negative in all cases (Figure 2h ).
Although the expected reactivity must be lower than with cryosections from frozen samples, a positive reaction was clearly observed in groups injected at 10 ml s -1 speed or more; however, comparative efficacy determination between the two procedures required molecular analysis.
Quantitative PCR and reverse transcriptase-PCR (RT-PCR) assays of eGFP
In order to determine the influence of flow rate (20 vs 10 vs 1 ml s -1 ) and total volume (1/10 vs 1/5 segment weight) of the injection upon gene transfer efficacy, we included an additional group (flow rate 20 ml s -1 and 1/5 ml volume of segment weight) in the abovedescribed histochemical study, resulting in the following groups: 20 ml s -1 (1/10 vol), 20 ml s -1 (1/5 vol), 10 ml s -1 (1/5 vol) and 1 ml s -1 (1/5 vol), whose pressures during hydrodynamic injection, in the tip of the introducer, were 122.0 ± 102.1, 190.8 ± 79.4, 93.4 ± 33.4 and 25.0 ± 12.3 mm Hg, respectively.
After liver segment transfection, performed as explained in the Materials and Methods, cultured samples were collected on days 1 and 2 after transfection to evaluate the index of both apparent gene delivery and transcription, on the basis of the number of molecule copies, employing quantitative PCR and RT-PCR, respectively. Several samples were collected from each segment after injection, always belonging to tissue areas corresponding to those seen to be perfused by the contrast pre-injection. The gene expression data obtained were not significantly different between samples A and B from each segment, with A being the area directly perfused and B the areas corresponding to lateral zones. The index of apparent eGFP gene delivery to liver tissue was evaluated as the ratio of eGFP DNA copies per 100 pg of total DNA. The term 'apparent' tries to remark that the index evaluates the total amount of DNA present in the tissue, without differentiating the functional ability. The results are summarized in Figure 3a , and indicate that the transgene was present in all liver tissue The human liver segments were retrogradely injected with saline solution containing 20 mg ml -1 of DNA plasmid bearing the eGFP gene. Different groups were established according to the different conditions of flow rate (1, 10 or 20 ml s -1 ) and total volume injected (1/5 or 1/10 of segment weight, in grams). Quantitative eGFP PCR or RT-PCR was performed in liver tissue samples collected 1 and 2 days after gene transfer from zones A and B, and the eGFP copy number in each sample was calculated on a standard curve using the same transfection plasmid. The index of apparent eGFP gene delivery to liver tissue (a) was calculated as the ratio of eGFP DNA copies per 100 pg of total DNA. Statistical significance by two-way analysis of variance (ANOVA) analysis and Bonferroni post-test was found in groups marked with *Po0.01 compared with 20 ml s -1 , 1/5 group. The index of tissue transcription (b) was calculated as the number of eGFP RNA copies per 100 pg of total RNA. No statistically significant differences were observed between groups except for 1 ml s -1 , 1/5 (Po0.05) by two-way ANOVA and Bonferroni post-test, marked with Asterisk (*).
Naked DNA delivery to ex vivo human liver segments MJ Herrero et al samples but significant differences were observed between groups: maximal values were observed in the 20 ml s -1 , 1/5 group, being statistically different from all other groups in zone A at the second day (Po0.01). The transcription index was evaluated as the amount of eGFP RNA copies per 100 pg of total RNA. The results are summarized in Figure 3b , and indicate that the transgene was present in all liver tissue samples from segments injected at X10 ml s -1 reaching from 10 5 to 2Â10 6 copies per 100 ng total RNA, approximately. In all cases, the highest values were observed on day 2 after transfection, but no statistically significant differences were observed between groups. However, once again, lower values were observed in segments injected with 1 ml s -1 , 1/5 vol (Po0.05, zone B, day 2). The apparent intrinsic gene efficacy (iE) indicates the amount of RNA produced per gene copy, and was evaluated as the ratio of RNA/ DNA copy of eGFP in each sample. We must note that this parameter, as its name indicates, is 'apparent' , and thus the values must be interpreted in the context of the experiment. The presence of extracellular or nonfunctional plasmids cannot be excluded, but it should be an interesting parameter for the relative comparison between groups. The results are summarized in Figure 4 , and show that higher apparent iE, B10 4 , was observed in the liver segments transfected with the injection flow rate of 10 ml s -1 , 1/5 vol, and continued to show similar values on days 1 and 2 post transfection, being significantly different (Po0.01) to all the other groups. However, in the segments transfected with 20 ml s -1 , apparent iE was lower (10 3 ) and decreased one order of magnitude in samples from zone A, day 2 with respect to day 1, mainly when the highest final volume (1/5 of segment weight) was employed. As iE is largely dependent on cell viability, we suspect that mild transfection conditions should offer cellular advantages for gene expression, as higher flow and volume values could mediate cell damage, resulting in a time-dependent gene iE decrease. When perfusion conditions are too slow (1 ml s -1 ), the intrinsic efficacy is dramatically reduced (B10 À1 ), suggesting that the functionality of the delivered DNA must be very limited. Regarding A and B zones, significant differences between them were only found in 10 ml s -1 , 1/5 group (Po0.01).
Transmission electron microscopy
Relevant morphological changes in the liver after hydrodynamic injection, mainly endothelial disruption and massive endocytic vesicles in hepatocytes, have been previously described in mice and pigs. 2, 4, 5, 8 To confirm whether these morphological changes also occur in humans, the liver segments were retrogradely injected at a 20 ml s -1 flow rate with buffered 2.5% glutaraldehyde solution. Then, tissue samples were collected for transmission electron microscopy (TEM). Figure 5 shows a representative image at low magnification of a venous sinusoid and four details (boxes a-d), at higher magnification, of different areas containing vascular endothelium, Disse space and Figure 4 Index of apparent gene intrinsic efficacy in liver tissue. Experimental conditions of transfection and molecular analysis of the liver samples were as described in Figure 3 . The index of apparent iE was calculated as the ratio of RNA/DNA copy of eGFP in each sample, and indicates the amount of RNA produced per DNA gene copy. The statistical significance between groups is indicated as *Po0.01 when comparing groups against 10 ml s -1 , 1/5. # Po0.01 Statistical significance between A and B zones inside the group by two-way analysis of variance (ANOVA) and Bonferroni post-test. apical hepatocytes. The main morphological changes observed were: (1) dilated sinusoid; (2) very small changes, if any, in the sinusoidal endothelium, without signs of disruption; and (3) dilated space of Disse at some sites, without massive endocytic vesicles in the hepatocytes. The morphological changes observed in the liver were smaller than expected, suggesting that anadromous DNA delivery to hepatocytes must involve facilitated permeation, not a membrane disruption process.
In order to reveal the possible existence of membrane disruption not directly observed by TEM, other liver segments were retrogradely injected at a 20 ml s -1 flow rate with buffered 2.5% glutaraldehyde solution containing gold nanoparticles (15 nm in diameter and 10 12 particles per ml). Because large amounts of gold nanoparticles are necessary for these experiments, the particles were prepared as described in the Materials and methods. The morphological characteristics of the nanoparticles and the diameter distribution are presented in Figure 6 . The mean nanoparticle diameter employed in this experiment was 15.5 ± 0.3 nm. The gold nanoparticle distribution in the liver segment is shown in Figure 7 , where the central image (at low magnification) shows a dilated sinusoid in which specific boxes, corresponding to sites of the endothelium-Disse space-hepatocyte (a-d), are amplified with the aim of identifying the location of nanoparticles. In all cases, nanoparticles were observed inside the sinusoid or within the Disse space. In no case were nanoparticles observed inside the hepatocytes, thus suggesting the absence of any hepatocyte membrane disruption, and the implication of a facilitated permeation process in DNA delivery to the liver cells.
DISCUSSION
The present work shows that anadromous gene delivery to 'ex vivo' human liver segments, mediated by retrograde injection of naked DNA encoding for the eGFP gene in the hepatic vein, results in efficient gene transfer as indicated by: (1) eGFP DNA, RNA identified by quantitative PCR and RT-PCR; (2) eGFP protein identified by fluorescent and immunohistochemistry procedures (in our hands, the best of the studied conditions for transfection was retrograde injection of a saline solution of eGFP plasmid (20 mg ml -1 ) at a flow rate of 10 ml s -1 and a final volume equivalent to 1/5 of the liver segment weight in grams); and (3) the ultrastructural studies employing gold nanoparticles suggest that the mechanism of gene delivery must be mediated by a facilitated permeation process, not by hepatocyte membrane disruption.
Important progress has been made in nonviral gene therapy since the hydrodynamic procedure for mouse liver gene delivery was first described. 2, [8] [9] [10] However, the systemic perturbation resulting from hydrodynamic injection remains a serious limitation for clinical application, as it can lead to circulatory collapse and even death. To avoid this adverse effect, we have described a retrograde cathetermediated gene delivery procedure 5 with the aim of locally reproducing the intrahepatic conditions mediated by tail vein hydrodynamic injection. However, all the studies reported in pigs 4, 5, [11] [12] [13] [14] and in human clinical trials 3 indicate that the efficiency of the procedure remains several orders of magnitude lower than observed in mice. The exact reason for the low gene transfer efficiency of retrograde injection is still unknown, but the low resistance of the sinusoid bed must be a very important factor, as DNA can easily travel across the liver segment after hepatic vein injection, reaching the portal vein and then freely returning to the inferior cava vein through another liver segment. 15 In the present work, we hypothesize that human 'ex vivo' liver segments must be excellent candidates for anadromous gene transfer, as the outflow of injected DNA solution from the targeted segment is blocked in the surgical removal process. In all cases, vascular patency before injection was confirmed by contrast injection and X-ray fluoroscopy. The injection conditions were similar to those employed in pig experiments for catheter-mediated 'in vivo' gene transfer, but with the advantage of blocking outflow of injected DNA solution. The results indicate that both 20 and 10 ml s -1 injection flow rates of a plasmid saline solution (20 mg ml -1 ) containing the eGFP gene mediate efficient gene transfer, as observed by light microscopy employing direct fluorescence or immunohistochemistry procedures. This observation confirms the preliminary hypothesis and supports the idea that outflow obstruction during DNA hepatic vein injection significantly contributes to increase the efficiency of hydrodynamic liver gene delivery. 7 However, when segments were injected with high volumes (1/5 vol) but low flow (1 ml s -1 ), we hardly found the protein expression in histological sections. The microscopic observations support the good efficacy of gene delivery in groups injected with X10 ml s -1 , but the eGFP gene encodes for a nonsecreted protein that accumulates within the cytoplasm, and therefore the amount of protein is poorly correlated with expression efficacy.
In order to evaluate how delivery and transcription of the eGFP gene contribute to liver gene transfer efficacy, two tissue indexes were used based on the number of DNA or RNA copies. The eGFP gene apparent delivery index (DNA copy number per 100 pg of total DNA) was 10 2 -10 4 eGFP copies per 100 pg of total DNA, approximately. The liver segments injected with 1 ml s -1 also showed lower index values. Interestingly, the value of the index decreases as the injection conditions become milder (in general, 20 ml s -1 1/5 4 20 ml s -1 1/10 Figure 6 Gold nanoparticle characterization. The gold nanoparticles were prepared as described in the Materials and Methods. The morphological characteristics of the gold nanoparticles were examined by transmission electron microscopy (b), and the average diameter and size distribution (a) were determined by counting at least 300 nanoparticles.
Naked DNA delivery to ex vivo human liver segments MJ Herrero et al 4 10 ml s -1 1/5 4 1 ml s -1 1/5). However, we must remark that this index is of apparent distribution, and hence it does not analyze the functionality of the quantified DNA. Given that the copy number reached by the milder conditions is 10 2 , we could think that a great part of the injected DNA could reach the tissue but without functional ability, as supported by histochemical studies summarized in Figure 2 . If we consider that 3.3 pg DNA is equivalent to a haploid human genome, 16 our results suggest an equivalent efficacy of 10-1000 eGFP gene copies per cell, approximately. The eGFP gene transcription index (RNA copy number per 100 ng of total RNA) was 10 5 to 2Â10 6 copies per 100 ng total RNA, approximately, in groups injected with X10 ml s -1 , but 2 to 3 orders of magnitude lower when injected with 1 ml s -1 , 1/5 vol. In all cases, the highest values were observed 2 days after transfection in groups injected at X10 ml s -1 . Although no significant difference was observed between those groups, the liver segments injected with 10 ml s -1 showed slightly higher index values at day 1 post injection.
The apparent iE (RNA/DNA copy number of a gene) is an interesting parameter, because it indicates the level of functionality of the introduced gene inside the cell, on the base of how many copies of RNA molecules are transcribed from each DNA molecule delivered to the tissue sample. We must note that this 'apparent' parameter must be interpreted in the context of the experiment. The presence of extracellular or nonfunctional plasmids cannot be excluded, and therefore in those cases in which the proportion of extracellular plasmids was very elevated, the indexes could not be accurate measures of the efficiency. Anyway, they could be interesting parameters for the relative comparison between groups. Our results indicate that apparent iE decreased 10 times from days 1 to 2 after transfection in both groups of liver segments injected at a 20 ml s -1 flow rate, mainly in A zones where the hydrodynamic impact was higher. However, similar values for the 2 days were observed in the group injected at a 10 ml s -1 flow rate. In addition, higher values of apparent iE were also observed in the group of 10 ml s -1 compared with the groups of 20 ml s -1 , suggesting that milder injection conditions must offer cell advantages for gene expression, and confirming that outflow obstruction 7 must contribute to increase the efficiency of hydrodynamic liver gene delivery. Interestingly, when the lowest flow was employed (1 ml s -1 ), the apparent iE was dramatically reduced up to 5 orders of magnitude, suggesting that in these conditions the efficiency of the hydrodynamic procedure is very low. This finding supports our previous statement that the amount of gene delivered was in great part not able to be functional. We hypothesize, based on these results, that all the procedures of DNA injection with X10 ml s -1 mediate a similar efficacy of transcription, as the index of transcription shows, and that the special watertight conditions must probably be contributing to reduce the minimum necessary requirements to reach the hydrodynamic gene transfer. However, the more extreme conditions (more speed and volume) contribute to an increase of DNA copies in the tissue (index of apparent gene delivery) but whose functionality (ability of expressing the gene) must probably be limited, as the apparent intrinsic efficacy is lower regarding the milder condition group (10 ml s -1 ). In any case, the mechanism of anadromous gene transfer mediated by hydrodynamic injection remains unclear. Previously, our group (employing simultaneous portal and cava vein pressures and intravital microscopic evaluation of sinusoidal blood circulation) described that the mechanism of hydrodynamic liver gene transfer involves the inversion of sinusoidal blood flow because of transient inversion of portal versus cava vein differential pressures. Also, morphological changes were associated with the intrahepatic pressures, mainly an increased diameter of the sinusoids and Disse space, as well as increased endothelial disruption and the presence of abundant endocytic vesicles in the apical pole of hepatocytes. 8 The rapid increase in both the inferior cava and portal vein pressures mediated by hydrodynamic injection suggests a low vascular resistance, but pressure in the inferior cava vein remains higher for fewer minutes, resulting in an inverted sinusoidal flow. More recently, it has been proposed 17 that during hydrodynamic injection, retrograde DNA solution reaches the portal vein, where the vascular resistance of the intestinal, splenic and pancreatic capillary beds provides efficient outflow obstruction from the portal vein, and thus outflow obstruction is a necessary condition for effective hydrodynamic gene delivery to individual liver segments or lobes. 7, 18 The results of the present paper confirm in human 'ex vivo' liver segments that outflow obstruction in hydrodynamic injection of the eGFP gene results in wide gene delivery and efficient gene expression.
The exact mechanism of gene delivery mediated by hydrodynamic injection remains unknown, but two routes of entry of DNA plasmids into hepatocytes have been suggested: plasma membrane rupture 19 and increased membrane permeation, 5, 8, 20, 21 possibly through endocytic vesicles. In the present study we confirm that hydrodynamic injection mediates an increase in sinusoid diameter, with an endothelium that combines both continuous and discontinuous zones, although in no case was generalized disruption observed. In addition, the usually narrow Disse space presented an expanded aspect compatible with an increased flow/pressure in this territory. Although some endocytic vesicles or at least incipient vesicles were observed in the apical membrane of hepatocytes, we failed to find territories with abundant endocytic processes lining the hepatocyte membrane, as previously described in mice and pigs. We do not know the reason for this difference, and although it could be because of species-related structural differences, the 'ex vivo' conditions also imply that liver segments were deprived of vascular supply 2 to 3 h before hydrodynamic injection, and therefore a loss of cell endocytic response could be possible. However, we cannot exclude that these discrepancies could be because of suboptimal conditions of the experimental model that could be improved. Although the degree of endocytic vesicles could limit the efficiency of the process, this fact could be compensated by an increase of membrane permeation due to the special conditions of the hepatic segments in our experiments.
To evaluate how this circumstance could contribute to minimal rupture of the plasma cell membrane of hepatocytes permitting DNA entry into the cell, additional experiments were performed, injecting gold nanoparticles with a mean diameter of 15 nm. The results indicate that the nanoparticles were always located in the vascular bed and within the Disse space, but never inside hepatocytes, thus supporting the idea that a permeation process must be involved in the gene transfer process. In this context, facilitated permeation is related to the ability of DNA to cross the cell membrane in the particular scenario of hydrodynamic injection. Two questions must be remarked. Although nanoparticles and plasmid size could be similar, the rigidity characteristics are very different and this could explain their different ability to cross the cell membranes. The second point is that higher concentrations of injected nanoparticles could contribute to clarify the degree of membrane permeation to these particles. In summary, we have shown that the retrograde venous injection of 'ex vivo' human liver segments is an anadromous procedure that can mediate good efficacy of gene delivery and gene expression in human liver, with potential clinical applications. In this respect, we believe that this gene transfer procedure could be a promising option in the field of human liver transplantation, as genetically modified grafts could contribute to decrease ischemia-reperfusion injury or prevent allograft rejection, as recently suggested. 22 
MATERIALS AND METHODS
Liver segments
Human liver segments were obtained from surgical resections of tumor metastatic patients. The liver segments came from surgery to patients and the fragments resected were sealed together with the remaining piece of liver inside the patient in the manner the surgeons usually do in the clinical practice: the liver parenchyma was sealed by 3/0 silk sutures or staples when the vessels were bigger than 2 to 3 mm and by electrocautery when smaller.
The number of segments used in the eGFP molecular studies were 19, corresponding to 19 human livers. Of 10 segments, 14 samples were used for fluorescence or immunohistochemistry. Finally, for ultrastructural change studies without (n¼3) or with gold nanoparticles (n¼3), 6 additional human liver segments were employed. Table 1 shows the main characteristics of all the human liver segments employed, including anatomical situation, segment weight, the experimental injection conditions performed and the kind of analyses in each segment.
We state that the Declaration of Helsinki protocols were followed and that patients gave their written, informed consent. This research was approved by the clinical research ethics committee of the Hospital Clínico Universitario of Valencia (Spain).
Reagents
The primary anti-GFP antibody was obtained from Abcam (ab290, Cambridge, MA, USA), and the peroxidase-conjugated antibody and immunohistochemical developing system (LSAB) were obtained from DAKO (Barcelona, Spain).
The plasmid p3C-EGFP (6.45 kb), containing the enhanced green fluorescent protein complementary DNA (cDNA) driven by the pCMV promoter, was constructed by cloning EGFP into the HindIII site of pcDNA3 (Invitrogen, Barcelona, Spain), excised from pEGFP-N1 (4.7 kb) plasmid vector (Clontech Laboratories, Saint-Germain-en-Laye, France).
Gold nanoparticle synthesis
All chemicals were purchased from Sigma-Aldrich (Madrid, Spain) and used as received without further purification. Gold nanoparticles were synthesized following a modification of the Turkevich method. 23 Typically, 0.4 g of HAuCl4.3H2O was dissolved in 90 ml of water in a two-neck round flask (1.3 mM HAuCl4). The resulting solution was heated to boiling and refluxed. Then, 9 ml of a 47.2 mM sodium citrate solution (0.125 g sodium citrate in 9 ml water) was preheated and quickly added. The solution turned from yellow to black and to deep red. After the color changed, the solution was refluxed for 20 min. Then, the heater was turned off and the solution was stirred until it reached room temperature. The resulting solution was diluted with water to a final volume of 500 ml. Gold nanoparticles were characterized by TEM (Jeol 1010, Tokyo, Japan). The average diameter and the size distribution of the gold nanoparticles were determined from TEM images by counting at least 300 nanoparticles using Image Pro Plus software from Media Cybernetics (Bethesda, MD, USA).
'Ex vivo' gene transfer to liver segment
Human liver segments (418.0 ± 227.2 g) were obtained from patients after surgical resection of liver metastases. Samples were immediately transported under humid and sterile box conditions to the laboratory, and all experimental processing was completed in B1.5 h, employing sterile solutions and aseptic conditions. A flexible 8F introducer (used as catheter), filled with saline solution, was placed into the hepatic vein previously marked by the surgeon. After catheter fixation using needle and thread, in all experiments, contrast solution was injected before hydrodynamic injection to confirm a correct positioning of the catheter and balloon closure of the vein. Always, the contrast injection was at low speed (not hydrodynamical) and employing a maximum volume of B1% of segment weight (3-10 ml). The visualization of a well-defined vascular tree was required before performing the hydrodynamic injection.
For gene transfer study, a volume of 1/5 or 1/10 of the segment weight, bearing 20 mg ml -1 of plasmid in saline solution containing the eGFP gene, was injected at a 10 or 20 ml s -1 flow rate. A low injection flow group was also included, being injected at 1 ml s -1 and with the highest volume, 1/5. During the experiment of hydrodynamic injection, the pressure (mm Hg) at the tip of the introducer was continuously monitorized using an auxiliary access. A Spectramed Statham pressure transducer (model P23XL, Oxnard, CA, USA) and a Grass model 7 polygraph (preamplifier model 7P1J and amplifier model 7DAG, West Warwick, RI, USA) were employed. After injection, we waited 5 min to remove the catheter.
Then, tissue samples were obtained from perfused areas. Tissue samples o1 mm in thickness were subsequently collected under sterile conditions and cultured in Dulbecco's modied Eagle's medium and a 5% CO 2 atmosphere. Samples were removed 1 and 2 days after transfection and processed for molecular analysis to evaluate the efficiency of gene delivery and the persistence of eGFP expression.
For morphological studies, the same procedure was performed, but injecting a solution containing 15 nm gold nanoparticles (1.8Â10 12 Au particles per ml) for further electron microscopy observations.
Quantitative PCR and RT-PCR
Liver tissue samples were cut into small pieces and homogenized in Tri Reagent (Ambion, Applied Biosystems, Madrid, Spain) with an Ultra-Turrax (Hielscher Ultrasonics GmbH, Teltow, Germany) homogenizer. Subsequently, the RNA samples were treated with RNase free DNase (Gibco, Invitrogen, Barcelona, Spain). Further purification with the RNeasy mini-kit (Qiagen, Barcelona, Spain) was performed before spectrophotometric quantification. Retrotranscription to cDNA was performed using 1 mg total RNA (DNA free), Random Hexamers and a High Capacity cDNA Archive kit (Applied Biosystems). For quantitative RT-PCR, power SYBR green PCR master mix (Applied Biosystems) was employed according to the instructions of the manufacturer.
The oligonucleotides were designed with Primer Express software (Applied Biosystems). The primers specific for eGFP were:
FW: 5¢-GTAAACGGCCACAAGTTCAGC-3¢, Tm: 53.9 1C RV: 5¢-TGGTGCAGATGAACTTCAGGG-3¢, Tm: 54.9 1C Probe: 5¢-6FAM-CTTGCCGTAGGTGGC-MGBNFQ-3¢ The precise amount of RNA (based on optical density) and its quality (lack of degradation) were normalized with respect to an endogenous control gene (glyceraldehyde 3-phosphate dehydrogenase (GAPDH)). The quantitative data were calculated as the number of DNA or RNA copies on a regression curve employing the plasmid containing the eGFP gene or full human DNA, considering that 3 pg of DNA contains a genome copy. 16 Statistically significant differences between groups were evaluated by twoway analysis of variance followed by Bonferroni post-tests, employing Graph Pad Prism 4.02 Software (GraphPad Software, San Diego, CA, USA).
Fluorescent and immunohistochemical eGFP identification
For fluorescent study, liver cryosections from human segments (n¼7) cultured 24 h after transfection were used. The cryosections were examined and photographed using a Zeiss Axiovert 135 inverted microscope (Carl Zeiss, Madrid, Spain).
For immunohistochemical study, liver samples (n¼7) were fixed in 4% paraformaldehyde and embedded in paraffin. Immunostaining was carried out Abbreviations: F, optical fluorescence microscopy for enhanced green fluorescent protein (eGFP); IHC, optical microscopy for immunohistochemistry of eGFP protein; TEM, transmission electron microscopy; TEM-Gold, transmission electron microscopy after gold nanoparticle injection. The table includes the experimental injection conditions performed and the kind of analyses in each segment, being PCR, molecular analyses of PCR and/or reverse transcriptase-PCR (RT-PCR).
as previously described. 2 Briefly, deparaffinized tissue sections were incubated with 4% bovine serum albumin in phosphate-buffered saline (1 h, 37 1C). Then, the tissue sections were incubated in antibody solution (1:300 diluted rabbit anti-GFP) at 37 1C for 1 h. The respective control samples incubated in the absence of specific antibody were included. Detection was carried out using the LSAB-2 peroxidase kit (DAKO). Tissue was counterstained with hematoxylin before dehydration.
Electron microscopy
Human liver segments (n¼3) were retrodynamically injected (volume 1/5 of segment weight) through the catheter placed in the hepatic vein with a buffered solution of 2.5% glutaraldehyde. Additional experiments (n¼3) were performed under identical conditions of glutaraldehyde injection but containing 10 12 gold particles per ml, to study the liver distribution of 15 nm gold nanoparticles after injection. Then, in both cases small tissue pieces from different liver areas were removed and immersed in phosphate Sørensen buffer (pH 7.4) solution containing 2.5% glutaraldehyde. For TEM, multiple 1-mm 3 pieces of liver were routinely processed and embedded in Epoxy resin. Ultrathin sections, stained with uranyl acetate and lead citrate, were examined under a Jeol JEM-1010 electron microscope.
